News – Page 131 – Endpoints News

Tracon to seek ‘strategic’ options; Ovid to lay off 17 workers

10 months ago

Lilly inks radiopharma deal with Radionetics, with rights to buy the biotech

10 months ago

Aerovate plans to lay off nearly all employees after trial failure

10 months ago

Eisai takes over development of ADC after Bristol Myers ends $650M collaboration

10 months ago

Dianthus teases preclinical data for autoimmune drug as it starts clinical trials

10 months ago

Artiva refiles for IPO three years after original plans in a vastly different environment

10 months ago

Alnylam's big Phase 3 win; LGBTQ+ leaders charting paths; Chevron overturned; and more

10 months ago

EMA's CHMP recommends 10 new drugs as Pierre Fabre overactive bladder med wins approval

10 months ago

Merck calls ACIP's pneumococcal recommendation a 'missed opportunity,' advocates for expanding age group

10 months ago

Federal grand jury indicts Cassava collaborator for allegedly defrauding NIH

10 months ago

CMS spells out how states can join new cell and gene therapy access pilot

10 months ago

Why the Supreme Court's overrule of Chevron has major implications for the FDA

10 months ago

Inside BARDA's multibillion-dollar effort to fund long-shot biotechs for Covid

10 months ago

Rovi teases acquisition offers for its CDMO unit potentially worth €2B to €3B

10 months ago

J&J details Phase 3 success of autoimmune disease drug, touting broader range than argenx’s Vyvgart

10 months ago

Savara’s $100M offering; New biotech to test Eisai drug in Ph2

10 months ago

FDA rejects Rocket Pharma’s ultra-rare immune disease gene therapy over manufacturing

10 months ago

Autoimmune brain disease startup Arialys gets new leader; Intellia, Arvinas appoint CFOs

10 months ago

Immunology biotech Alumis secures $250M in shrunken IPO

10 months ago

Lykos takes another hit as ICER lays out 'insufficient' evidence for MDMA-based treatment

10 months ago

House panel advances bill to allow Medicare to cover obesity drugs

10 months ago

What Coherus' $40M sale of its Humira biosimilar says about the crowded market

10 months ago

Supreme Court narrowly rejects Purdue bankruptcy plan, says it gives Sacklers too much protection

10 months ago

To tackle a deadly brain disease, scientists devise small but charming epigenetic editing tool

10 months ago

First page Previous page 128 129 130131132 133 134 Next page Last page